Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-005904

Chief Scientific Officer sold 1,412 shares at $11.78 ($16,633)

  • Chief Scientific Officer acquired 3,207 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hansen Gwenn Chief Scientific Officer 2023-01-30 Option exercise +3,207 24,421 D: show line 1 in the form
Hansen Gwenn Chief Scientific Officer 2023-01-30 Sale −1,412 $11.78 $16,633 23,009 D: show line 2 in the form
Open-market sales · 1,412 sh · avg $11.78 · $16,633

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hansen Gwenn Chief Scientific Officer 2023-01-30 Option exercise · Restricted Stock Units −3,207 38,481 D: show line 3 in the form
Loading xslF345X03/doc4.xml…